Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eye-based glucose monitor developer expands series A

This article was originally published in Clinica

Executive Summary

Freedom Meditech, a developer of noninvasive ophthalmic devices for monitoring glucose levels in diabetics, has expanded its series A financing after raising an additional round of funds. The amount invested in the second tranche was not disclosed. Participants in the round include existing shareholder JumpStart Ventures and various individual investors. Additionally, the company welcomed new investor Catherine Stiefel, a long-time director of Stiefel Laboratories and now also a director on Freedom's board. Cleveland, Ohio-based Freedom is developing a handheld device that is designed to provide immediate glucose level readings by shining a light in the eye.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel